Related Experiment Video
Updated: Aug 12, 2026
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency
M E North1, G P Spickett, A D Webster
1Immunodeficiency Diseases Research Group, Clinical Research Centre, Harrow, England, UK.
Insights
Common Variable Immunodeficiency (CVI) patients show elevated levels of soluble CD8, soluble CD25, and beta 2-microglobulin. These markers correlate with disease severity and B cell defects, suggesting abnormal cellular activation in CVI.
Area of Science:
- Immunology
- Clinical Medicine
- Biochemistry
Background:
- Common Variable Immunodeficiency (CVI) is a primary immunodeficiency characterized by hypogammaglobulinemia.
- The underlying mechanisms and biomarkers for CVI are not fully understood.
- Assessing immune cell activation markers may provide insights into CVI pathogenesis.
Purpose of the Study:
- To investigate serum levels of soluble immune markers in CVI patients.
- To correlate these levels with disease severity and B lymphocyte defects.
- To explore potential indicators of cellular activation in CVI.
Main Methods:
- Serum samples were collected from patients with CVI and healthy controls.
- Levels of soluble CD8, soluble CD4, soluble CD25 (IL-2 receptor), beta 2-microglobulin, and TNF-alpha were quantified.
- Data were analyzed to compare CVI patients with controls and correlate marker levels with clinical and in vitro assessments.
Main Results:
- Significantly elevated serum levels of soluble CD8, soluble CD25, and beta 2-microglobulin were observed in CVI patients compared to normal controls.
- Soluble CD4 and TNF-alpha levels did not show significant elevation in CVI patients.
- Elevated markers correlated with the extent of B lymphocyte defects and clinical disease severity in CVI.
- Patients with X-linked agammaglobulinaemia did not exhibit similar elevations.
Conclusions:
- Raised serum levels of soluble CD8, soluble CD25, and beta 2-microglobulin are characteristic of CVI.
- These findings suggest abnormal cellular activation in CVI patients.
- The elevated soluble markers may contribute to the immunodeficiency observed in CVI.
Abstract:
Soluble CD8, soluble CD4, soluble CD25 (IL-2 receptor), beta 2-microglobulin and the cytokine tumour necrosis factor-alpha (TNF-alpha) were measured in sera from patients with common variable immunodeficiency (CVI). Levels of soluble CD8, soluble CD25 and beta 2-microglobulin but not of soluble CD4 and TNF-alpha were raised significantly above levels in normal sera. Sera from patients with X-linked agammaglobulinaemia, who are also antibody deficient, did not show this marked elevation. The raised levels of soluble CD8, soluble CD25 and beta 2-microglobulin in CVI, correlated with the extent of the defects in the B lymphocytes assessed in vitro, as well as with the clinical severity of the disease. The selective release of these molecules into sera may indicate that abnormal cellular activation occurs in most CVI patients. It is also possible that the raised levels of these soluble molecules play a part in the immunodeficiency.
